Saturday, July 25, 2026
Live
Welcome to Whispers in the Corridors — Politcs. Bureaucracy. Corporate Fresh stories from the corridors of power, delivered daily.
Corporate

DBT-BIRAC Biopharma Entrepreneurship Promotion

DBT’s BIRAC (est. 2012) announced expanded support for startups in pharma/biopharma via grants and interfaces. Includes new calls for monoclonal antibodies against Nipah virus. Trending: Indigenous manufacturing push, with ₹1,000 Cr RDI outlay for private R&D.

By Whispers in the Corridors 1 min read

DBT’s BIRAC (est. 2012) announced expanded support for startups in pharma/biopharma via grants and interfaces. Includes new calls for monoclonal antibodies against Nipah virus. Trending: Indigenous manufacturing push, with ₹1,000 Cr RDI outlay for private R&D.

Share

Comments (0)

Comments are moderated before they appear.

No comments yet. Be the first.